147 related articles for article (PubMed ID: 38411778)
21. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
22. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E
J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781
[TBL] [Abstract][Full Text] [Related]
23. Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study.
Lee JY; Chong YP; Kim T; Hong HL; Park SJ; Lee ES; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
J Antimicrob Chemother; 2014 Jul; 69(7):1966-71. PubMed ID: 24695351
[TBL] [Abstract][Full Text] [Related]
24. A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremia.
Jorgensen SCJ; Lagnf AM; Bhatia S; Rybak MJ
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):843-850. PubMed ID: 30734879
[TBL] [Abstract][Full Text] [Related]
25. No effect of vancomycin MIC ≥ 1.5 mg/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia.
Bouiller K; Laborde C; Aho SL; Hocquet D; Pechinot A; Le Moing V; Bertrand X; Piroth L; Chirouze C
Int J Antimicrob Agents; 2018 May; 51(5):721-726. PubMed ID: 29305961
[TBL] [Abstract][Full Text] [Related]
26. The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study.
Steinhaus N; Al-Talib M; Ive P; Boyles T; Bamford C; Davies MA; Mendelson M; Wasserman S
Int J Infect Dis; 2018 Aug; 73():78-84. PubMed ID: 29908251
[TBL] [Abstract][Full Text] [Related]
27. Complicated and uncomplicated S. aureus bacteraemia: an international Delphi survey among infectious diseases experts on definitions and treatment.
Hagel S; Bahrs C; Schumann R; Pletz M; Weis S
Clin Microbiol Infect; 2022 Jul; 28(7):1026.e7-1026.e11. PubMed ID: 35358683
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.
Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Martín-Gandul C; López-Medrano F; de Gopegui ER; Ramón Blanco J; García-Pardo G; Calbo E; Horcajada JP; Granados A; Jover-Sáenz A; Dueñas C; Pujol M;
Clin Microbiol Infect; 2014 Apr; 20(4):361-7. PubMed ID: 23991832
[TBL] [Abstract][Full Text] [Related]
29. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
[TBL] [Abstract][Full Text] [Related]
30. Ceftaroline for the treatment of methicillin-resistant
White BP; Barber KE; Stover KR
Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
[TBL] [Abstract][Full Text] [Related]
31. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
Britt NS; Patel N; Shireman TI; El Atrouni WI; Horvat RT; Steed ME
J Antimicrob Chemother; 2017 Feb; 72(2):535-542. PubMed ID: 27999028
[TBL] [Abstract][Full Text] [Related]
32. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
33. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
34. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study.
Verhagen DW; van der Meer JT; Hamming T; de Jong MD; Speelman P
Scand J Infect Dis; 2003; 35(8):459-63. PubMed ID: 14514144
[TBL] [Abstract][Full Text] [Related]
35. Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
Neuner EA; Casabar E; Reichley R; McKinnon PS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):228-33. PubMed ID: 20542203
[TBL] [Abstract][Full Text] [Related]
36. A predictive rule for mortality of inpatients with Staphylococcus aureus bacteraemia: A classification and regression tree analysis.
Kobayashi D; Yokota K; Takahashi O; Arioka H; Fukui T
Eur J Intern Med; 2014 Dec; 25(10):914-8. PubMed ID: 25459214
[TBL] [Abstract][Full Text] [Related]
37. Emergence of multidrug-resistant sequence type 45 strains among mecA-positive borderline oxacillin-resistant Staphylococcus aureus causing bacteraemia in a medical centre in Taiwan.
Huang YT; Liao CH; Chen SY; Hsu HS; Teng LJ; Hsueh PR
Int J Antimicrob Agents; 2018 Jul; 52(1):70-75. PubMed ID: 29505885
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome.
Kim T; Kim ES; Park SY; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Chong YP; Kim YS
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607
[TBL] [Abstract][Full Text] [Related]
40. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
